Clevecord

Cleveland Cord Blood Center (CCBC) is a non-profit biotechnology organization dedicated to the collection, processing, and distribution of umbilical cord blood for use in stem cell transplants. The organization's primary commercial product, Clevecord, is an FDA-approved hematopoietic progenitor cell (HPC) therapy indicated for use in patients with disorders of the hematopoietic system, including certain cancers and genetic conditions. CCBC operates as a public cord blood bank, maintaining a diverse registry of high-quality units available for patients globally. In addition to its clinical operations, the center conducts research into advanced cellular therapies and regenerative medicine. The organization is headquartered in Cleveland, Ohio, and maintains partnerships with leading medical institutions to advance the field of cord blood transplantation.